Tuesday, March 21, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Unfolding Protein “Filmed” for the First Time

by Global Biodefense Staff
February 14, 2013

Unfolding of the CylR2 proteinA team of researchers led by the Max Planck Institute for Biophysical Chemistry and the German Center for Neurodegenerative Diseases is the first to image the various stages of a protein’s unfolding, which may lend valuable insight to treatment of a number of diseases.

Protein folding and unfolding are crucial for a range of biological phenomena and human disease states. Conditions such as Alzheimer’s and Parkinson’s, for example, are caused by misfolded proteins that form insoluble clumps in the brain and eventually destroy the nerve cells. Understanding how proteins achieve or lose their three-dimensional structure is one of the most important questions in the biological sciences because proteins can only perform their functions properly if their amino acid chains are correctly folded.

But what exactly happens when proteins fold or unfold was previously nearly impossible to investigate. With heat and pressure, proteins easily lose their shape – and thus their function. Such methods are not suitable for directly observing their unfolding process, as the intermediate forms that occur are too transient.

By combining low temperatures and NMR spectroscopy, the scientists visualized seven intermediate forms of the CylR2 protein while cooling it down from 25°C to – 16°C. This particular protein was chosen because it is made of two identical subunits, which the team believed would make it easier to visualize.  CylR2 is also a key protein for toxin production in Enterococcus faecalis, a pathogen frequently encountered in hospitals where it particularly jeopardizes patients with a weak immune system. 

Their results show that the most instable intermediate form plays a key role in protein folding and serves as a trigger point. The scientists’ findings may contribute to a better understanding of how proteins adopt their structure and misfold during illness.

“If a protein is slowly cooled down, its intermediate forms accumulate in larger quantities than in commonly used denaturation methods, such as heat, pressure, or urea. We hoped that these quantities would be sufficient to examine the intermediate forms with nuclear magnetic resonance (NMR) spectroscopy,” said Markus Zweckstetter, head of the research group.

The research was conducted in collaboration with the Polish Academy of Sciences in Warsaw and the University of Warsaw. The study was published this week in Nature Chemical Biology: Cold denaturation of a protein dimer monitored at atomic resolution. 

Image: “Snapshot” of the unfolding of the CylR2 protein from Enterococcus faecalis. If the protein is cooled from 25°C to -16°C, it successively breaks down into its two identical subunits. The latter are initially stable, but at -16°C they form an instable, dynamic protein form, which plays a key role in folding. 

Source: Max Planck Institute

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC